More important, every country is testing differently. Knowing the real denominator, the true number of people who become infected, is key to determining what portion of them die. Some countries, the U.S. among them, have had trouble making enough tests available. When there’s a shortage of tests, the sickest get tested first. And even with a good supply of tests, someone who’s otherwise healthy and has mild symptoms may not be tested and thus go uncounted.